1 / 40

Chapter 4- Antigens & Antibodies

Chapter 4- Antigens & Antibodies. Where we’re going- Immunogenicity vs antigenicity What makes for a good immunogen (aka antigen) Haptens. Some definitions:. Immunogenicity Immunogen, for practical purposes= antigen

Download Presentation

Chapter 4- Antigens & Antibodies

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Chapter 4- Antigens & Antibodies Where we’re going- Immunogenicity vs antigenicity What makes for a good immunogen (aka antigen) Haptens

  2. Some definitions: • Immunogenicity • Immunogen, for practical purposes= antigen • Antigenicity- ability to react with antibodies or Tcells; all immunogens are antigens, but haptens have antigenicity but not immunogenicity. (if this sounds confusing…)

  3. Haptens • Loved by some immunologists-esp. old ones! Haptens aren’t immunogenic alone. BUT- when bound to a carrier, Ab’s are produced that DO bind to the unbound hapten

  4. Haptens in real life- allergies to penicillin

  5. So how do we tell a good antigen from a poor one? Inject with antigen- isolate serum, and react with antigen to produce, say, precipitation; the more dilute the serum can be, and still ppt the Ag, the better the response. Discuss more in Chapter 6

  6. Immunogen’s contribution- usually think “protein” • Foreignness- cow vs chimp serum albumin; “shielded” parts from us- mitochondrial proteins, sperm. • Size- > 100K better, < 10K worse, especially for proteins • Complexity- homopolymers poor, heteropolymers better • Easily processed better than poorly processed; adding L-amino acids to a D-polymer increases its immunogenicity.

  7. “Our” Contribution- both the animal and how immunization is done • Genetics- mouse studies- responders and non-responder mice. • Dosage and route of administration- the pneumococcal polysaccharide story. • Route determines which lymph tissues meet the antigen- e.g., spleen vs local lymph nodes. (know the terms, p.80)

  8. Our contribution- adjuvants • Something that stimulates the immune response to the antigen. • Alum- ppt’s, prolongs persistence • Inflammatory- dead Mycobacterium • Non-specific proliferation of cells- LPS,

  9. Epitopes, or Ag determinants • Our cells don’t react to the whole molecule, but to parts- epitopes • B cells react to differently to epitopes than do T cells. • Remember- interaction is specific!

  10. How B cells do it An epitope can be non-sequential- 56-62 and 15-21 can be brought together spatially, producing a single epitope. B cell eptitopes tend to be on the surface,.

  11. This is a strange graph- by measureing inhibition, it essentially measures binding; antibody was to the native structure.

  12. How T cells do it The binding is ternary- three components- MHCII, TCR, antigen. Only parts are displayed. No MHC binding= no antigenicity B cell eptitopes tend to be on the surface, but T cells can be from the interior of the molecule.

  13. A mystery- be able to explain for the exam!

  14. Antibodies • Where we’re going: • Learn about Ab structure: constant, variable, Fab, Fc, hypervariable, CDR regions. • Five different classes: G,M,A,E,D • Functional differences • Isotypes, allotypes, idiotypes • Monoclonals, and variants

  15. In SERUM- liquid left from clotted blood Antibodies here- black is what happens when induced Ab’s are removed (anti-OVA)

  16. Binds Ab still Binds complement, ppt’s in the cold, only constant region

  17. We know these things from myelomas, and plasmacytomas induced in mice w/ mineral oil (MOPC)

  18. Mostly beta sheets w/hinge regions

  19. Hypervariable= CDR= Ag binding regions- towards the outside of V domain. Complementarity determining region

  20. Variability= # different amino acids at a given position- Frequency of most common AA e.g.- 10 different AA’s in a position, most frequent is at 0.2, variability= 50

  21. What do Antibodies do? • Bind antigen- neutralize toxins, virus particles • Opsonization • Complement activation- IgG,M • ADCC • Transcytosis- movement across epithelial cells

  22. A tour of the Antibody Classes

  23. Most abundant 4 subclasses Activates complement Crosses placenta See notes! Secreted Multiple forms (1-4) NOT inflammatory!

  24. A short ad for breast milk- 5th ed.

  25. Antibodies can also be antigens- develop Ab’s agains mouse Ab’s in a bunny. Isotypic = class determinants Allotypic- allelic differences between the same Ig Idiotypic: differences due to antigen-binding differences

  26. New topics The B Cell receptor (tails) and superfamilies, and monoclonals

  27. New topics: Tails and Superfamilies Ig-α,Ig-β allow for signal transduction Tails of mIgM and mIgD are only 3 amino acids-too short for signal transduction

  28. Some Ig superfamilies- similarity in structure, but not necessarily function. Thought to arise by gene duplication and evolution

  29. Monoclonal Antibodies Ab’s from a single clonal line of B cells. The problem: differentiated B cells/plasma cells won’t divide. Solution: fuse with immortal cancer cell, to make LOTS of Mab

  30. HAT medium: HGPRT- myeloma cells die HGPRT+ B cells don’t multiply.

  31. Hypoxanthine and thymine from salvage HGPRT- X Myeloma cell-can divide, but poisoned!  Aminopterin X De Novo synthesis

  32. Hypoxanthine and thymine from salvage HGPRT+ B cell- resists poison, but can’t divide!  Aminopterin X De Novo synthesis done in

  33. Hypoxanthine and thymine from salvage HGPRT+ Fusion: can divide! Resists poison!  Aminopterin X De Novo synthesis done in

  34. Immunotoxins! A long-time promise. Actual monoclonals against B cells are out there, in use, now.

  35. Key Points- See Learning Objectives! • General structure of Ab’s: L & H chains, V & C regions, Ab binding region, Fc, CDRs, etc. • Unique characteristics of each Ab • Superfamilies, Monoclonals

More Related